Open Access
Med Sci (Paris)
Volume 38, Number 4, Avril 2022
Page(s) 366 - 373
Section M/S Revues
Published online 29 April 2022
  1. Dema B, Charles N. Autoantibodies in SLE: Specificities. Isotypes and Receptors. Antibodies (Basel) 2016 ; 5 : 2. [Google Scholar]
  2. La Cava A.. Putting together the autoimmunity puzzle. J Clin Invest 2015 ; 125 : 2184–2186. [CrossRef] [PubMed] [Google Scholar]
  3. Neiman M, Hellstrom C, Just D, et al. Individual and stable autoantibody repertoires in healthy individuals. Autoimmunity 2019 ; 52 : 1–11. [CrossRef] [PubMed] [Google Scholar]
  4. Dema B, Charles N. Advances in mechanisms of systemic lupus erythematosus. Discov Med 2014 ; 17 : 247–255. [PubMed] [Google Scholar]
  5. Kaul A, Gordon C, Crow MK, et al. Systemic lupus erythematosus. Nat Rev Dis Primers 2016 ; 2 : 16039. [CrossRef] [PubMed] [Google Scholar]
  6. Terrier B, Mouthon L. Lupus érythémateux systémique : traitements par anticorps monoclonaux et molécules recombinantes. Med Sci (Paris) 2013 ; 29 : 65–73. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  7. Lee DSW, Rojas OL, Gommerman JL. B cell depletion therapies in autoimmune disease: advances and mechanistic insights. Nat Rev Drug Discov 2021; 20 : 179–99. [CrossRef] [PubMed] [Google Scholar]
  8. Anders HJ, Saxena R, Zhao MH, et al. Lupus nephritis. Nat Rev Dis Primers 2020; 6 : 7. [CrossRef] [PubMed] [Google Scholar]
  9. Charles N. Autoimmunity, IgE and FcepsilonRI-bearing cells. Curr Opin Immunol 2021; 72 : 43–50. [CrossRef] [PubMed] [Google Scholar]
  10. Lamri Y, Vibhushan S, Pacreau E, et al. Basophils and IgE contribute to mixed connective tissue disease development. J Allergy Clin Immunol 2021; 147 : 1478–89 e11. [CrossRef] [PubMed] [Google Scholar]
  11. Pellefigues C, Dema B, Lamri Y, et al. Prostaglandin D2 amplifies lupus disease through basophil accumulation in lymphoid organs. Nat Commun 2018 ; 9 : 725. [CrossRef] [PubMed] [Google Scholar]
  12. Karasuyama H, Miyake K, Yoshikawa S, Yamanishi Y. Multifaceted roles of basophils in health and disease. J Allergy Clin Immunol 2018 ; 142 : 370–380. [CrossRef] [PubMed] [Google Scholar]
  13. Miyake K, Shibata S, Yoshikawa S, Karasuyama H. Basophils and their effector molecules in allergic disorders. Allergy 2021; 76 : 1693–706. [CrossRef] [PubMed] [Google Scholar]
  14. Pellefigues C, Mehta P, Chappell S, et al. Diverse innate stimuli activate basophils through pathways involving Syk and IkappaB kinases. Proc Natl Acad Sci USA 2021; 118 : e2019524118. [CrossRef] [PubMed] [Google Scholar]
  15. Charles N, Watford WT, Ramos HL, et al. Lyn kinase controls basophil GATA-3 transcription factor expression and induction of Th2 cell differentiation. Immunity 2009 ; 30 : 533–543. [CrossRef] [PubMed] [Google Scholar]
  16. Denzel A, Maus UA, Rodriguez Gomez M, et al. Basophils enhance immunological memory responses. Nat Immunol 2008 ; 9 : 733–742. [CrossRef] [PubMed] [Google Scholar]
  17. Charles N, Hardwick D, Daugas E, et al. Basophils and the T helper 2 environment can promote the development of lupus nephritis. Nat Med 2010 ; 16 : 701–707. [CrossRef] [PubMed] [Google Scholar]
  18. Rodriguez Gomez M, Talke Y, Goebel N, et al. Basophils support the survival of plasma cells in mice. J Immunol 2010; 185 : 7180–5. [CrossRef] [PubMed] [Google Scholar]
  19. Otsuka A, Nakajima S, Kubo M, et al. Basophils are required for the induction of Th2 immunity to haptens and peptide antigens. Nat Commun 2013 ; 4 : 1739. [CrossRef] [PubMed] [Google Scholar]
  20. Camussi G, Tetta C, Benveniste J. Detection of basophil sensitization by IgE antibodies to nuclear antigens in connective tissue diseases. Int Arch Allergy Appl Immunol 1982 ; 69 : 358–362. [CrossRef] [Google Scholar]
  21. Pan Q, Gong L, Xiao H, et al. Basophil Activation-Dependent Autoantibody and Interleukin-17 Production Exacerbate Systemic Lupus Erythematosus. Front Immunol 2017 ; 8 : 348. [PubMed] [Google Scholar]
  22. Dema B, Pellefigues C, Hasni S, et al. Autoreactive IgE is prevalent in systemic lupus erythematosus and is associated with increased disease activity and nephritis. PloS one 2014 ; 9 : e90424. [CrossRef] [PubMed] [Google Scholar]
  23. Lamri Y, Charles N. IgE in the Pathogenesis of SLE: From Pathogenic Role to Therapeutic Target. Antibodies (Basel) 2020; 9. [Google Scholar]
  24. Dema B, Charles N, Pellefigues C, et al. Immunoglobulin E plays an immunoregulatory role in lupus. J Exp Med 2014 ; 211 : 2159–2168. [CrossRef] [PubMed] [Google Scholar]
  25. Halfon M, Bachelet D, Hanouna G, et al. CD62L on blood basophils: a first pre-treatment predictor of remission in severe lupus nephritis. Nephrol Dial Transplant 2021; 12 : 2256–62. [CrossRef] [PubMed] [Google Scholar]
  26. Oon S, Monaghan K, Ng M, et al. A potential association between IL-3 and type I and III interferons in systemic lupus erythematosus. Clin Transl Immunology 2019 ; 8 : e01097. [PubMed] [Google Scholar]
  27. Renner K, Hermann FJ, Schmidbauer K, et al. IL-3 contributes to development of lupus nephritis in MRL/lpr mice. Kidney Int 2015 ; 88 : 1088–1098. [CrossRef] [PubMed] [Google Scholar]
  28. Dema B, Lamri Y, Pellefigues C, et al. Basophils contribute to pristane-induced Lupus-like nephritis model. Sci Rep 2017 ; 7 : 7969. [CrossRef] [PubMed] [Google Scholar]
  29. Henault J, Riggs JM, Karnell JL, et al. Self-reactive IgE exacerbates interferon responses associated with autoimmunity. Nat Immunol 2016 ; 17 : 196–203. [CrossRef] [PubMed] [Google Scholar]
  30. Sapkota B, Al Khalili Y. Mixed Connective Tissue Disease. StatPearls. Treasure Island (FL)2021. [Google Scholar]
  31. Greidinger EL, Zang Y, Jaimes K, et al. A murine model of mixed connective tissue disease induced with U1 small nuclear RNP autoantigen. Arthritis Rheum 2006 ; 54 : 661–669. [CrossRef] [PubMed] [Google Scholar]
  32. Greidinger EL, Zang YJ, Jaimes K, et al. CD4+ T cells target epitopes residing within the RNA-binding domain of the U1–70-kDa small nuclear ribonucleoprotein autoantigen and have restricted TCR diversity in an HLA-DR4-transgenic murine model of mixed connective tissue disease. J Immunol 2008 ; 180 : 8444–8454. [CrossRef] [PubMed] [Google Scholar]
  33. Leyva-Castillo JM, Hener P, Michea P, et al. Skin thymic stromal lymphopoietin initiates Th2 responses through an orchestrated immune cascade. Nat Commun 2013 ; 4 : 2847. [CrossRef] [PubMed] [Google Scholar]
  34. Musio S, Costanza M, Poliani PL, et al. Treatment with anti-FcepsilonRIalpha antibody exacerbates EAE and T-cell immunity against myelin. Neurol Neuroimmunol Neuroinflamm 2017 ; 4 : e342. [CrossRef] [PubMed] [Google Scholar]
  35. Pellefigues C, Naidoo K, Mehta P, et al. Basophils promote barrier dysfunction and resolution in the atopic skin. J Allergy Clin Immunol 2021; 148 : 799–812 e10. [CrossRef] [PubMed] [Google Scholar]
  36. Hasni S, Gupta S, Davis M, et al. Safety and Tolerability of Omalizumab: A Randomized Clinical Trial of Humanized Anti-IgE Monoclonal Antibody in Systemic Lupus Erythematosus. Arthritis Rheumatol 2019 ; 71 : 1135–1140. [CrossRef] [PubMed] [Google Scholar]
  37. Maurer M, Gimenez-Arnau AM, Sussman G, et al. Ligelizumab for Chronic Spontaneous Urticaria. N Engl J Med 2019 ; 381 : 1321–1332. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.